Abstract
Surveillance after treatment of anal carcinoma is not as firmly established as surveillance for colorectal cancer. The rarity of the disease means that there is a paucity of data or clinical trials comparing different regimens. The current standard of care for squamous cell carcinoma of the anus consists of combined modality treatment, with a surveillance regimen that aims at detecting recurrent or persistent disease, assessing treatment tolerance and related complications, with salvage surgery being reserved for locoregional failures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Prestage G, Ferris J, Grierson J, et al. Homosexual men in Australia: population, distribution and HTV prevalence. Sex Health. 2008;5:97–102.
National Health and Medical Research Council (NHMRC). Clinical practice guidelines for the prevention, early detection and management of colorectal cancer. The Cancer Council Australia, Australian Cancer Network, The Commonwealth of Australia, Canberra; 2005.
Fleshner P, Chalasani S, Chang G, et al. Practice parameters for anal squamous neoplasms. Dis Colon Rectum. 2008;51:2–9.
Young SC, Solomon MJ, Hruby G, Frizelle FA. Review of 120 anal cancer patients. Colorectal Dis. 2009;11:909–14. Epub 2008 Oct 25.
Christensen A, Nielsen M, Svendsen L, Engelholm S. Three-dimensional anal endosonography may improve detection of recurrent anal cancer. Dis Colon Rectum. 2006;49:1527–32.
Goldman S, Svensson C, Bronnergard M, Glimelius B, Wallin G. Prognostic significance of serum concentration of squamous cell carcinoma antigen in anal epidermal carcinoma. Ing J Colorectal Dis. 1993;8:98–102.
Petrelli NJ, Palmer M, Herrera L, Bhargava A. The utility of squamous cell carcinoma antigen for the follow-up of patients with squamous cell carcinoma of the anal canal. Cancer. 1992;70:35–9.
Tasevski R, De Winton E, Ngan S, Mackay J, Hicks R, Heriot A. CR13 utility of 18- fluorodeoxyglucose PET in the staging and management of anal cancer. ANZ J Surg. 2007;77(Suppl sl):A17.
Roohipour R, Patil S, Goodman K, et al. Squamous-cell carcinoma of the anal canal:·predictors of treatment outcome. Dis Colon Rectum. 2008;51:147–53.
Gervaz P, Hirschel B, Morel P. Molecular biology of squamous cell carcinoma of the anus. Br J Surg. 2006;93:531–8.
Place R, Gregorcyk S, Huber P, Simmang C. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma. Dis Colon Rectum. 2001;44:506–12.
Martin F, Bower M. Anal intraepithelial neoplasia in HIV positive people. Sex Transm Infect. 2001;5:327–31.
Hoffinan R, Welton M, Klencke B, Weinberg V, Krieg R. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys. 1999;44:127–31.
Ajani J, Winter K, Gunderson L, et al. Fluorouracil, mitomycin and radiotherapy vs fluorouracil, cisplatin and radiotherapy for carcinoma of the anal canal. JAMA. 2008;299:1914–21.
Renehan A, Saunders M, Schofield P, O’Dwyer S. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. Br J Surg. 2005;92:605–14.
Mariani P, Ghanneme A, De la Rochefordiere A, Girodet J, Falcou M, Salmon R. Abdominoperineal resection for anal cancer. Dis Colon Rectum. 2008;51:1495–501.
Nilsson PJ, Svenson C, Goldman S, Glimelius B. Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg. 2002;89:1425–9.
Ferenschild F, Vermaas M, Hofer SO, Verhoef C, Eggermont A, de Witt JHW. Salvage abdominoperineal resection and perineal wound healing in local recurrent or persistent anal cancer. World J Surg. 2005;29:1452–7.
Sunesen KG, Buntzen T, Lindegaard J, Norgaard M, Laurberg S. Perineal healing and survival after anal cancer salvage surgery: 10-year experience with primary perineal reconstruction using the vertical rectus abdominis myocutaneous flap. Ann Surg Oncol. 2009;16:68–77. Epub 2008 Nov 5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Humana Press
About this chapter
Cite this chapter
El-Khoury, T., Solomon, M., Young, J. (2013). Anal Carcinoma Surveillance Counterpoint: Australia. In: Johnson, F., et al. Patient Surveillance After Cancer Treatment. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-969-7_39
Download citation
DOI: https://doi.org/10.1007/978-1-60327-969-7_39
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60327-968-0
Online ISBN: 978-1-60327-969-7
eBook Packages: MedicineMedicine (R0)